If one part of success in Silicon Valley is dependent on your ability to stay up all night and code, the other part depends on your ability to think outside the box. Some in the Valley are trying to force creativity by taking LSD.
“What’s In My Baggie?” is a documentary on the rise of misrepresented substances, as well as a critique of ineffective drug policy.
According to the European Monitoring Centre for Drugs and Drug Addiction, over 250 new drugs have been discovered since 2009.
There are so many different psychoactive drugs floating around that people don’t even realize the complex nature of the current situation.
To document our findings, we filmed substance test kit results at music festivals, as well as interviews with harm reduction organizations, law enforcement officials, and distributors of these illicit substances.
We quickly discovered that most of the time people were surprised to find that their bag of drugs was not what they paid for.
For more info, visit whatsinmybaggie.com
It’s one thing to say that psychedelic mushrooms “open your mind,” but it’s another entirely to demonstrate its dream-like effects in a scientific study. Yet, that’s what one group of researchers appear to have achieved in a study published today in Human Brain Mapping.
In the experiment, researchers injected a dose of psilocybin — the chemical that gives “shrooms” their kick — into a group of 15 participants, reports The Washington Post. Another group, the control, didn’t receive the drug. Then, using brain imaging technology, the researchers looked at the areas of the brain that were activated in both groups. This allowed them to determine that psilocybin increased the volume of activity in regions of the brain that are usually activated when we dream, during sleep. It also increased brain function in regions that are associated with emotion and memory. According to the researchers, these effects are akin to what we experience when we dream.
Amber Lyon, 3-time Emmy award winning journalist, describes how her work as a journalist covering social justice issues lead to her suffering from Posttraumatic Stress Disorder and how experience with Ayahuasca cured her of the disorder and led to a radical spiritual and career shift.
For more visit reset.me
Alexander ‘Sasha’ Shulgin is the scientist behind more than 200 psychedelic compounds including MDMA, more commonly known as Esctasy. Considered to be one of the the greatest chemists of the twentieth century, Sasha’s vast array of discoveries have had a profound impact in the field of psychedelic research. ‘Dirty Pictures’ delves into the lifework of Dr. Shulgin and scientists alike, explores the world of these scientists; their findings and motivations, their ideas, and their beliefs as to how research in this particular field can aid in unlocking the complexities of the mind.
It’s generally not the best idea to go to work while you’re high on anything, it can be a health and safety hazard especially if you are working around heavy machinery. But this guy (Sam Briggs’) get’s some pretty good footage of himself wrapping Christmas presents while high on Coke, LSD and Ketamine.
Being Christmas, Briggs was manning a Christmas gift wrapping stall during the course of his “experiment,” with his bosses being none the wiser:
The people renting out the stall and the public obviously have no clue that Sam is buzzing off his tits the whole time, but they’ll both be glad to know that all money raised went to charity.
It turns out that psychedelics aren’t just good for turning into an elf and jousting a car. Psychiatrists, psychologists and specialists in addiction and recovery from traumatic experiences have been investigating the use of hallucinogens in treatment programs, and the results indicate that psychedelics actually have practical therapeutic uses. And one drug has proven particularly useful. Repeated studies have found the psychedelic compound found in magic mushrooms, psilocybin, can help people move past major life issues — like beating alcoholism and becoming more empathetic.
The research: One study concluded that controlled exposure to psilocybin could have long-lasting medical and spiritual benefits. In 2011, Johns Hopkins researchers found that by giving volunteer test subjects just the right dose (not enough to give them a terrifying bad trip), they were able to reliably induce transcendental experiences in volunteers. This provoked long-lasting psychological growth and helped the volunteers to find peace in their lives, all without side effects. Nearly all of the 18 test subjects, average age 46, were college graduates. Seventy-eight percent were religious and all were interested in finding a scientific experience.
Fourteen months later, 94% said their trip on magic mushrooms was one of the five most important moments of their lives. Thirty-nine percent said it was the most important thing that had ever happened to them. Their colleagues, friends, and family members said the participants were kinder and happier; the volunteers had positive experiences ranging from more empathy and improved marriages to less drinking.
Lead author Roland Griffiths told TIME’s Healthland that “The important point here is that we found the sweet spot where we can optimize the positive persistent effects and avoid some of the fear and anxiety that can occur and can be quite disruptive.”
What’s more, the researchers say that those changes in personality are highly atypical, because personalities tend to be pretty set in stone after the age of 25-30. According to postdoctoral researcher Katherine MacLean, who contributed to the study, “This is one of the first studies to show that you actually can change adult personality.”
“Many years later, people are saying it was one of the most profound experiences of their life,” she continued. “If you think about it in that context, it’s not that surprising that it might be permanent.”
Watch video and keep reading: http://www.policymic.com/articles/89829/scientists-studied-what-psychedelics-do-to-the-brain-and-it-s-not-what-you-ve-been-told?utm_source=policymicFB&utm_medium=main&utm_campaign=social
The coexistence between trees and fungi is supposed to be very peaceful. Fungi grow on the roots of a plant, providing nitrogen to it in exchange for carbon, in a nearly perfect symbiotic exchange. Each individual fungus, traditional wisdom holds, works in tune with the root it grows in tandem with. But a new study presents a different model: The supposed buddies are actually acting like buyers and sellers in a capitalist market.
Led by IIASA Ecosystems Services and Management researcher Oskar Franklin, the Swedish study (paywall) started with a surprising observation. Root fungi were actually working to maintain nitrogen scarcity in the forest. When less nitrogen was available in the soil, fungi gave up less nitrogen to the trees. But when nitrogen was abundant, they built up their stores like speculators cornering the market in a commodity, effectively forcing the trees to get their nitrogen from the fungi no matter what.
“The new theory pictures a more business-like relationship among multiple buyers and sellers connected in a network,” Franklin said in a press release. Instead of being a cooperative trade of carbon and nitrogen between organisms, trees are forced to export large amounts of carbon in order to unlock nitrogen stores from the fungi.
What’s more, fungi can play clients off against one another. When different plants get their nitrogen from one fungal partner, the study states, the allocation of nitrogen to each of those plants isn’t dictated by need or fairness. Instead, the fungus seeks the best possible return on investment. “Having multiple symbiotic trading-partners generates competition among both the fungi and the plants,” Franklin said, “where each individual trades carbon for nutrients or vice versa to maximize profits, not unlike a capitalistic market economy.”